Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. To further refine your search, toggle appropriate sections on or off.
For recently married James "Rocky" Lagno molecularly targeted therapy for his non-small cell lung cancer meant a return to a quality of life similar to what he enjoyed prior to his diagnosis.
Medha Deoras-Sutliff’s experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers.
For nearly two decades Randy Surratt was in and out of treatment for hairy cell leukemia. A clinical trial at the NIH has the Michigan man in “complete” remission.
Brain cancer survivor Lanette Veres sends cards and packages to others with the disease. She believes no one should face cancer alone.
After surviving stage 3B non-small cell lung cancer, Tomma worked to support others with the disease and now works as a patient lay navigator.
When Keith's salivary gland cancer spread throughout his body and he was given just weeks to live, the Oklahoma City man turned to a clinical trial for a therapy that targeted the mutation driving his disease. Read Keith's survivor story.
When chemotherapy didn't halt her cancer, Donna Fernandez turned to an immunotherapy trial drug to keep the disease in check.
Jazz musician and educator Billy Foster continues to work on his music as he battles metastatic kidney cancer.
Carly Flumer reflects on being diagnosed with thyroid cancer four months into her graduate program.
After being diagnosed with stage 4 triple-negative breast cancer, Eva Joseph enrolled in a clinical trial for an immunotherapy-chemotherapy that has her enjoying retirement with her husband again.
Your donation to the American Association for Cancer Research helps our more than 47,000 members worldwide drive progress against cancer.